Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an ...
Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...
Zacks.com on MSN
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and Zepbound fuel ...
Obesity products gain momentum in India and globally as multinationals leverage smart pricing and collaborations amidst ...
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? Investors will be watching what Trump makes happen.
The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...
Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...
The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new ...
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus ahead of a major drug pricing deal with the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback